Why Your Testosterone Crashes Between Injections and How Injection Frequency Fixes It
Testosterone crashing between injections is one of the most commonly reported complaints from UK steroid users and men on self-administered TRT. The pattern is consistent: you inject, feel noticeably better within a day or two, then by day five or six the energy dips, the mood drops, the libido falls, and you are counting down to the next injection. This is not a problem with the compound. It is a problem with the dosing interval. Understanding the pharmacokinetics of Testosterone Cypionate explains exactly why it happens and how a simple change to injection frequency resolves it.
How testosterone ester pharmacokinetics create peaks and troughs
Testosterone Cypionate does not release testosterone into the bloodstream instantly. The cypionate ester is attached to the testosterone molecule and must be cleaved by enzymes at the injection site before free testosterone enters circulation. This esterification process creates a slow-release profile. Serum testosterone rises gradually after injection, peaks at 24 to 48 hours, then declines as the ester continues to be metabolised.
The half-life of Testosterone Cypionate is approximately eight days. This means that eight days after a 250mg injection, approximately 125mg of equivalent testosterone remains active. After 16 days, approximately 62.5mg remains. The full clearance of a single injection takes five half-lives, which is approximately 40 days.
ScienceDirect’s clinical overview of Testosterone Cypionate confirms that at a dose of 200 to 250mg, peak and trough values are clearly higher and lower than the normal range when injected every two to three weeks. This is the core problem. A once-weekly injection of 250mg produces a supraphysiological peak in the first 48 hours followed by a progressive decline. By day six or seven the trough is significantly lower than the peak. The user experiences the difference between these two states as the crash.
What the crash actually feels like and why it is misidentified
The symptoms of a pre-injection trough are often attributed to other causes. Low energy, mood flatness, reduced motivation, diminished libido, poor sleep quality and a general sense of feeling worse than during the first few days after injection are the classic trough symptoms. Most users attribute this to diet, sleep, training load or stress rather than recognising it as a pharmacokinetic event.
The timing is the diagnostic clue. If symptoms consistently appear in the 24 to 48 hours before your next injection and resolve within 24 to 48 hours after it, the cause is the trough. The body is experiencing a meaningful drop in serum testosterone from the peak it reached two days post-injection. The difference between that peak and the current trough is felt as a qualitative decline in wellbeing.
The crash is amplified by oestrogen dynamics. Aromatisation is highest at peak testosterone, which means oestradiol is also at its highest point in the 48 hours after injection. As testosterone falls toward the trough, oestradiol falls with it but on a different timeline. The relative oestrogen-to-testosterone ratio shifts as testosterone declines faster than oestradiol clears. Some users experience oestrogen-dominant symptoms at trough despite absolute oestradiol values that are not particularly high, simply because the ratio has shifted.
Why once-weekly injection produces the most pronounced crash
Once-weekly injection is still used by many UK steroid users, particularly for bodybuilding cycles where the cycle dose is high enough that the total weekly volume makes injection frequency feel less important. At bodybuilding doses of 500mg per week, even the trough after a single weekly injection leaves serum testosterone significantly above the physiological range. The crash is felt less acutely at high cycle doses than at TRT doses.
At TRT doses of 100 to 200mg per week, the once-weekly injection problem is much more pronounced. TRT Source’s 2026 protocol guide documents that a 400mg dose every two weeks creates a supraphysiological spike followed by a crash below baseline, which is exactly the pattern that causes patients to report feeling great for five days then terrible. The same principle applies at lower doses on a weekly schedule, just with a less extreme amplitude.
The Endocrine Society’s 2018 Clinical Practice Guidelines on testosterone therapy noted that injection intervals should be tailored to maintain serum testosterone within the normal range throughout the entire dosing period, not just at peak. Once-weekly dosing at most TRT doses fails this criterion because the trough frequently drops toward or below the lower reference range by day six or seven.
How twice-weekly injection solves the crash
Splitting the same weekly dose into two equal injections every 3.5 days changes the pharmacokinetic profile fundamentally. Rather than a single large peak followed by a long decline, the curve becomes two smaller peaks with shallower troughs between them. The trough before the second injection of the week is higher than the trough before the single weekly injection would have been at the same total dose.
Research referenced by TRT Source found that twice-weekly injection protocols reduce peak-to-trough fluctuations by 30 to 40% compared to weekly dosing. This reduction in amplitude is what eliminates the crash. The user no longer descends from a supraphysiological peak to a near-trough nadir within seven days. Instead, they maintain serum testosterone within a narrower, more stable range throughout the week.
The oestrogen benefit compounds this. Smaller testosterone peaks mean smaller aromatisation spikes. The peak oestradiol value reached after a twice-weekly injection is lower than after an equivalent single weekly injection. The ratio of testosterone to oestradiol remains more consistent throughout the week. Both the androgenic and oestrogenic hormone environment becomes more stable.
The practical numbers for Intex Pharma TC-250
Intex Pharma Testosterone Cypionate contains 250mg per ml. At a beginner cycle dose of 300mg per week, the twice-weekly injection is 150mg per injection, which is 0.6ml. At 500mg per week, it is 250mg per injection, which is 1ml. Both are manageable volumes for intramuscular injection.
The injection days that produce the most consistent spacing are Monday and Thursday, or Tuesday and Friday, or any pairing that splits the week into two equal 3.5-day intervals. Consistency of timing matters. Injecting on Monday morning and Friday evening creates a 4.5-day gap and a 2.5-day gap, which partially defeats the purpose of splitting the dose.
For users currently injecting once weekly who are experiencing the trough crash pattern, the transition to twice-weekly dosing does not require changing the total weekly dose. Simply divide the current weekly volume by two and inject that amount twice per week at equal intervals. Bloodwork at six to eight weeks after the protocol change will confirm that trough testosterone has risen and that peak values have moderated.
When frequency alone does not solve the problem
Not every case of feeling worse before an injection is caused by the pharmacokinetic trough. Two other scenarios produce similar symptoms and require different responses.
The first is oestrogen imbalance that is not frequency-related. If oestradiol is significantly elevated or significantly suppressed throughout the cycle rather than just fluctuating with the injection cycle, the symptoms may persist regardless of injection frequency. Mid-cycle bloodwork that includes oestradiol alongside total and free testosterone is the only reliable way to distinguish between a trough-driven crash and an oestrogen management problem.
The second is an underdosed product. If the compound is not at the stated concentration, serum testosterone will not reach the expected peak after injection. The bloodwork result at peak will be lower than expected for the stated dose. This is not a frequency problem and is not solved by injecting more frequently. It is a product quality problem. Every batch of Intex Pharma Testosterone Cypionate is independently tested by Janoshik Analytical with the Certificate of Analysis published in the product gallery before purchase, specifically to rule out this variable.
Bloodwork protocol for dialling in injection frequency
The most informative bloodwork for assessing injection frequency is trough measurement taken on the morning of your injection day before the injection itself. This gives the lowest point of your cycle. Compare this against a peak measurement taken 24 to 48 hours after the previous injection. The difference between these two values is your peak-to-trough amplitude.
A well-dialled twice-weekly protocol at TRT doses should produce trough total testosterone of 400 to 700 ng/dL and peak values of 700 to 1000 ng/dL, with the difference between them narrow enough that no qualitative crash is felt between injections. If the trough is below 300 ng/dL on a twice-weekly protocol, the dose is too low or the injection interval needs further reduction to every other day. If the peak exceeds 1200 ng/dL, the dose is too high regardless of how the trough looks.
Free testosterone and SHBG should be included alongside total testosterone. Some men with high SHBG have adequate total testosterone but insufficient free testosterone. This produces trough symptoms at total testosterone values that look normal on paper. The free testosterone value is the functionally relevant number, not the total alone.
Available now at Intex Pharma UK
Intex Pharma Testosterone Cypionate — in stock at £39.00, same day despatch
Pharmaceutical grade TC-250, 250mg per ml. Next day UK delivery. Ships worldwide. 15% off when paying with Bitcoin using code INTEXBTC15.
Frequently asked questions
Why do I feel worse before my testosterone injection?
This is the pharmacokinetic trough. Testosterone Cypionate peaks at 24 to 48 hours after injection and then declines progressively over the following days due to its eight-day half-life. By day six or seven of a weekly injection protocol, serum testosterone has dropped significantly from its post-injection peak. The qualitative difference between the peak state and the trough state is felt as lower energy, mood, libido and motivation. Switching to twice-weekly injection at the same total dose reduces this amplitude by 30 to 40% and typically eliminates the crash.
How often should I inject Testosterone Cypionate to avoid crashes?
Twice weekly at equal intervals of 3.5 days is the standard recommendation for eliminating the trough crash on Testosterone Cypionate. Injecting on Monday and Thursday, for example, maintains consistent spacing. Some men with persistent trough symptoms on twice-weekly dosing benefit from every-other-day injection, which produces an even flatter hormone curve. Daily microdosing produces the flattest curve of all but is impractical for most users.
Does changing injection frequency require changing my dose?
No. The total weekly dose stays the same. If you are currently injecting 500mg once weekly, switching to twice weekly means injecting 250mg twice per week. The total testosterone entering the body each week is identical. Only the timing of delivery changes, which changes the pharmacokinetic profile rather than the total androgenic load.
Can the testosterone crash cause mood problems?
Yes. The fluctuation in serum testosterone between peak and trough affects mood, energy, motivation and cognitive clarity in a meaningful proportion of users. The crash is also accompanied by a shift in the oestrogen-to-testosterone ratio as testosterone declines faster than oestradiol clears, which can produce a relative oestrogen dominance state at trough even without absolute oestrogen elevation. Stable testosterone from optimised injection frequency is one of the most effective interventions for mood stability on cycle.
How long does it take to feel the benefit of switching to twice-weekly injection?
Most users notice improved stability within two to three weeks of switching to twice-weekly dosing. The full benefit in terms of stable bloodwork values takes four to six weeks for serum levels to reach the new steady state under the altered protocol. Running bloodwork at six to eight weeks after the protocol change gives the most accurate picture of whether the frequency adjustment has achieved the intended outcome.
What bloodwork should I check if I am experiencing testosterone crashes?
Run total testosterone, free testosterone, SHBG and oestradiol. Take the trough measurement on the morning of injection day before injecting, and a peak measurement 24 to 48 hours after the previous injection. The gap between these two values tells you the amplitude of your cycle. If trough testosterone is below 300 ng/dL on weekly dosing, switching to twice weekly at the same total dose will raise your trough significantly. If both peak and trough are low, the dose may need review or product quality should be verified.